Search

everythinglearnresearchcommunity

for

Search:↓

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

A mutation in the KRT82 gene is significantly associated with Alopecia Areata.

Apocrine type cutaneous mixed tumors often resemble hair follicles, sebaceous glands, and apocrine glands.

People with alopecia areata have higher levels of EGF in their blood than healthy people.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Cell adhesion molecules are important in the development of certain skin diseases.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Some people with chronic hair loss may have thyroid autoimmunity.

Basal-cell epitheliomas and the pilosebaceous tract share a unique keratin, distinguishing them from other skin areas.

The Fas/FasL pathway may play a role in alopecia areata.

Changes in genes FGA, VWF, and ACTG1 may contribute to pemphigus vulgaris.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Diseased horse foot skin shows increased keratin expression, similar to wound healing in mammals.

CD4 T cells can cause alopecia areata by activating CD8 T cells to attack hair follicles.

Regular monitoring of autoantibodies in ANA-positive patients with hair loss helps detect and treat lupus early.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Areata-like lupus can mimic alopecia areata but is a form of cutaneous lupus erythematosus.

3D-cultured dermal papilla cells are better at inducing hair follicles than adipose-derived stem cells.

Hair color is not a risk factor for developing alopecia areata.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.